Research Information System
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, vol.55, no.1, pp.21-25, 1999 (SCI-Expanded)
Objectives: To determine whether patients with idiopathic systemic lupus erythematosus (SLE) are associated with impaired CYP2D6 activity and to gain insight into whether there is an association between particular CYP2D6 genotypes and susceptibility to SLE, and whether CYP2D6 polymorphism is linked to any specific clinical features of SLE.